Phase I trial to assess the safety of CT P27 in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 18 Nov 2013
Price : $35 *
At a glance
- Drugs CT P27 (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors Celltrion
- 18 Nov 2013 Results published in the Media Release.
- 18 Nov 2013 Status changed from recruiting to completed.
- 05 Jul 2013 New trial record